Roundup NHL Lawsuit Filed Over Farmer’s Cancer Diagnosis Following Decades Of Use

A North Carolina farmer who developed non-Hodgkins lymphoma (NHL) indicates that the cancer diagnosis was a direct result of exposure to Roundup, after spraying the popular weedkiller for more than two decades.

The complaint (PDF) was filed by William Prince in the U.S. District Court for the Eastern District of North Carolina on May 26, alleging that Monsanto misrepresented the safety of Roundup and it’s active ingredient, glyphosate, resulting in long-term exposure that increases the cancer risk for farmers and others in the agriculture industry.

Prince states that he sprayed Roundup approximately 90 days each year, for at least 22 years, while working as a farmer between 1976 and 1998. Although he followed all safety and precautionary warnings while using Roundup, Prince was subsequently diagnosed with NHL, which has recently been identified as a potential risk associated with glyphosate contained in the weedkiller.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More See If You Qualify For Compensation

“Had [Monsanto] properly disclosed the risks associated with Roundup, Plaintiff would have avoided the risk of NHL by not using Roundup,” according to the complaint. “Defendant’s failure to provide adequate warnings and instructions regarding the dangers and risks associated with Roundup was a proximate cause of Plaintiff’s injuries.”

Concerns about the link between Roundup and NHL emerged in mid-2015, after the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as a likely cancer-causing agent.

Since then, hundreds of similar Roundup lawsuits have been filed by farmer, landscapers, agricultural works and others diagnosed with cancer following regular use of the weedkiller.

Given the similar questions of fact and law raised in the complaints, Prince’s case will be consolidated with other Roundup claims, which are centralized before U.S. District Judge Vince Chhabria in the Northern District of California as part of a federal MDL, or multidistrict litigation. However, if Roundup settlements or another resolution for the litigation is not reached following the coordinated pretrial proceedings, each of the cases may be remanded back to the U.S. District Court where it was originally filed for a separate trial date in the future.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.